Vector BioMed has developed a technology platform for designing and manufacturing the lentiviruses used to deliver cell and gene therapies. The startup is launching as the field continues to experience shortages of these viral vectors.
CDMO Startup Vector BioMed Launches to Fill Lentiviral Gap for Cell & Gene Therapies
